Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer

Strahlentherapie und Onkologie

Volumn 190, Issue 3, 2014, Pages 270-275

  Van Oorschot, B ^a   Assenbrunner, B ^a   Schuler, M ^b   Beckmann, G ^a   Flentje, M ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Lung cancer; Neoplasm metastasis; Palliative care; Radiotherapy; Treatment outcome

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; RADIATION INJURY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896342353     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0507-y     Document Type: Article

References (52)

1. Beli I, Koukourakis G, Platoni K et al (2010) Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature. Rev Recent Clin Trials 5:103-111
2. Berghmans T, Paesmans M, Sculier JP (2011) Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol 3:127-138
3. Bleher M, Bratengeier K, Richter J (1991) Assessment of radiotherapy plans: dose-volume histograms, integral effects and tumor control. Strahlenther Onkol 167:220-226
4. Campion FX, Larson LR, Kadlubek PJ et al (2011) Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes. J Oncol Pract 7(3 Suppl):31s-35s
5. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
6. Chen AB, Cronin A, Weeks JC et al (2013) Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol 31:558-564
7. Chow E, Abdolell M, Panzarella T et al (2009) Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 73:280-287
8. Colinet B, Jacot W, Bertrand D et al (2005) A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 93:1098-1105 (Pubitemid 41670692)
9. De Rijke JM, Schouten LJ, Velde GP ten et al (2004) Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer 46:233-245 (Pubitemid 39334825)
10. Duncker-Rohr V, Nestle U, Momm F et al (2013) Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity. Strahlenther Onkol 189:33-40
11. Earle CC, Park ER, Lai B et al (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133-1138 (Pubitemid 46594144)
12. Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC Cancer Staging Manual, 7th edn. Springer, New York
13. Enders CK (2010) Applied missing data analysis. Guilford, New York
14. Erridge SC, Gaze MN, Price A et al (2005) Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 17:61-67 (Pubitemid 40090198)
15. Fairchild A, Harris K, Barnes E et al (2008) Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 26:4001-4011
16. Fromme EK, Smith MD, Bascom PB et al (2010) Incorporating routine survival prediction in a U.S. hospital-based palliative care service. J Palliat Med 13:1439-1444
17. Gironés R, Torregrosa D, Gómez-Codina J et al (2011) Prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 72:108-113
18. Giroux Leprieur E, Lavole A, Ruppert AM et al (2012) Factors associated with long-term survival of patients with advanced non-small cell lung cancer. Respirology 17:134-142
19. Glare PA, Sinclair CT (2008) Palliative medicine review: prognostication. J Palliat Med 11:84-103
20. Goeckenjan G, Sitter H, Thomas M et al (2011) Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 65:39-59
21. Graham JW (2009) Missing data analysis: making it work in the real world. Annu Rev Psychol 60:549-576
22. Greer JA, Pirl WF, Jackson VA et al (2012) Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30:394-400
23. Gripp S, Moeller S, Bölke E et al (2007) Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25:3313-3320 (Pubitemid 47325618)
24. Gripp S, Mjartan S, Boelke E et al (2010) Palliative radiotherapy tailored to life expectancy in end-stage cancer patients. Cancer 116:3251-3256
25. Grose D, Devereux G, Milroy R (2011) Comorbidity in lung cancer: important but neglected. A review of the current literature. Clin Lung Cancer 12:207-211
26. Guadagnolo BA, Liao KP, Elting L et al (2013) Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31:80-87
27. Jacot W, Colinet B, Bertrand D et al (2008) Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 19:1458-1464
28. Kramer GW, Wanders SL, Noordijk EM et al (2005) Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 23:2962-2970 (Pubitemid 46224115)
29. Lester JF, Macbeth FR, Toy E et al (2006) Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 18:(4):CD002143
30. n A (1991) Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 63:265-270
31. Lutz T, Chow L, Hartsell W et al (2007) A review of hypofractionated palliative radiotherapy. Cancer 109:1463-1469
32. Mac Manus MP, Matthews JP, Wada M et al (2001) Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 3:CD002143 (Review. Update in: Cochrane Database Syst Rev 2006)
33. Maltoni M, Caraceni A, Brunelli C et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240- 6248
34. Maurer J, Hipp M, Schäfer C et al (2011) Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187:744-749
35. National Comprehensive Cancer Network (NCCN) Guidelines Non-Small Cell Lung Cancer, Version 2.2013. http://www.nccn.org/professionals/physician-gls/ pdf/nscl.pdf. Accessed 31 December 2013
36. Nestle U, Nieder C, Walter K et al (2000) A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 48:95-103 (Pubitemid 30488218)
37. Numico G, Russi E, Merlano M (2001) Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy? Lung Cancer 32:213-226 (Pubitemid 32487682)
38. Read WL, Tierney RM, Page NC et al (2004) Differential prognostic impact of comorbidity. J Clin Oncol 22:3099-3103 (Pubitemid 41103722)
39. Reinfuss M, Mucha-Małecka A, Walasek T et al (2011) Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer 71:344-349
40. Rodrigues G, Macbeth F, Burmeister B et al (2012) International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. Clin Lung Cancer 13:225-235
41. Salvo N, Hadi S, Napolskikh J et al (2009) Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review. Curr Oncol 16:16-28
42. Schröder C, Ivo M, Buchali A (2013) Does high-dose radiotherapy benefit palliative lung cancer patients? An intradepartmental comparison of two dose regimens. Strahlenther Onkol 189:771-776
43. Smith SL, Palma D, Parhar T et al (2011) Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival. Lung Cancer 72:39-44
44. Tang JI, Shakespeare TP, Lu JJ et al (2008) Patients' preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancerdagger. J Med Imaging Radiat Oncol 52:497-502
45. Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733-742
46. Timothy AR, Girling DJ, Saunders MI et al (2001) Radiotherapy for inoperable lung cancer. Clin Oncol (R Coll Radiol) 13:86-87 (Pubitemid 32377504)
47. Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176-181 (Pubitemid 36962641)
48. Toole M, Lutz S, Johnstone PA (2012) Radiation oncology quality: aggressiveness of cancer care near the end of life. J Am Coll Radiol 9:199-202
49. Turner NJ, Muers MF, Haward RA, Mulley GP (2005) Do elderly people with lung cancer benefit from palliative radiotherapy? Lung Cancer 49:193-202 (Pubitemid 40966747)
50. Oorschot B van, Rades D, Schulze W et al (2011) Palliative radiotherapy: new approaches. Semin Oncol 38:443-449
51. Oorschot B van, Schuler M, Simon A et al (2011) Patterns of care and course of symptoms in palliative radiotherapy: a multicenter pilot study analysis. Strahlenther Onkol 187:461-466
52. Wang T, Nelson RA, Bogardus A, Grannis FW Jr (2010) Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer 116:1518-5125